You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 17, September 28, 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Headache
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ischemic Colitis and Sumatriptan Use

James F. Knudsen, PhD, MD; Beverly Friedman, MBA, RPh; Min Chen, MS, RPh; Jerome E. Goldwasser, MD

Arch Intern Med. 1998;158:1946-1948.

Sumatriptan succinate, a serotonin-l (5-hydroxytryptamine-1) receptor agonist, is an antimigraine drug that is reported to act by selectively constricting intracranial arteries. Recently, vasopressor responses that are distinct from the cranial circulation have been demonstrated to occur in the systemic, pulmonary, and coronary circulations. Cases have been published of coronary vasospasm, myocardial ischemia, and myocardial infarction occurring after sumatriptan use. We report on the development of 8 serious cases of ischemic colitis in patients with migraine treated with sumatriptan.


From the Divisions of Neuropharmacologic Drug Products (Dr Knudsen) and Pharmacovigilance and Epidemiology, Office of Epidemiology and Biostatistics (Mss Friedman and Chen), Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Md; and the Department of Internal Medicine, Division of Gastroenterology, Cedars-Sinai Medical Center–UCLA School of Medicine, Los Angeles, Calif (Dr Goldwasser).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

A Surfeit of Serotonin: Sumatriptan and Serotonergic Antidepressants
Charles E. Schwartz, James F. Knudsen, Beverly Friedman, Min Chen, and Jerome E. Goldwasser
Arch Intern Med. 1999;159(10):1141-1142.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk of ischemic complications related to the intensity of triptan and ergotamine use.
Wammes-van der Heijden et al.
Neurology 2006;67:1128-1134.
ABSTRACT | FULL TEXT  

Tegaserod and Ischemic Colitis
Brinker et al.
NEJM 2004;351:1361-1364.
FULL TEXT  

Prophylaxis of menstrual migraine with triptans: Problems and possibilities
Loder
Neurology 2002;59:1677-1681.
ABSTRACT | FULL TEXT  

Sumatriptan-Associated Mesenteric Ischemia
Liu et al.
ANN INTERN MED 2000;132:597-597.
FULL TEXT  

A Surfeit of Serotonin: Sumatriptan and Serotonergic Antidepressants
Schwartz et al.
Arch Intern Med 1999;159:1141-1142.
FULL TEXT  

Association Between Sumatriptan Use and Ischemic Colitis?
JWatch General 1998;1998:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.